Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OVAS

OvaScience (OVAS) Stock Price, News & Analysis

OvaScience logo

About OvaScience Stock (NASDAQ:OVAS)

Advanced Chart

Key Stats

Today's Range
$6.24
$6.44
50-Day Range
$8.56
$17.10
52-Week Range
$0.66
$1.52
Volume
21,145 shs
Average Volume
163,131 shs
Market Capitalization
$225.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI.

Receive OVAS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OvaScience and its competitors with MarketBeat's FREE daily newsletter.

OVAS Stock News Headlines

URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
General Catalyst Group V LP's Net Worth
TMRW Life Sciences Names Louis Villalba Chief Executive Officer
See More Headlines

OVAS Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that OvaScience investors own include Synergy Pharmaceuticals (SGYP), OPKO Health (OPK), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Melinta Therapeutics (MLNT), TherapeuticsMD (TXMD) and Bed Bath & Beyond (BBBY).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OVAS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$50.97 million
Net Margins
-10,128.37%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$290,000.00
Price / Cash Flow
N/A
Book Value
$1.80 per share
Price / Book
3.50

Miscellaneous

Free Float
N/A
Market Cap
$225.73 million
Optionable
Not Optionable
Beta
3.11
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:OVAS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners